BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Genetown

  The Side Effects Of A Genzyme Corporation Deal; Already Benefiting From Firm’s Production Woes, Rivals Foresee Wider Opening

  August 12, 2010

   · 

  1 min read
• Genetown

  Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round

  August 12, 2010

   · 

  1 min read
• FDA

  U.S. FDA Panel Backs GlaxoSmithKline, Valeant Pharmaceuticals International Epilepsy Drug; Glaxo Stock Rises

  August 12, 2010

   · 

  6 min read
• Business

  Transgenomic, Inc. to Hold Second Quarter Financial Results Conference Call Today

  August 12, 2010

   · 

  1 min read
• Pharm Country

  Orthovita, Inc. Notes Publication by The Lancet of Study Demonstrating Efficacy of Vertebroplasty Vs. Conservative Treatment

  August 12, 2010

   · 

  1 min read
• Business

  NextWave Pharmaceuticals and Tris Pharma, Inc. Enter into CNS-focused Development and Commercialization Agreement

  August 12, 2010

   · 

  2 min read
• Business

  Furiex Pharmaceuticals, Inc. Reports Second Quarter 2010 Financial Results

  August 12, 2010

   · 

  1 min read
• Policy

  CardioNet, Inc. Provides Update on Litigation

  August 12, 2010

   · 

  1 min read
• BioMidwest

  PDL BioPharma, Inc. Completes Retirement of $61.7 Million of 2.75% Convertible Notes Due August 2023 for Common Stock

  August 12, 2010

   · 

  2 min read
• Business

  Vermillion Reports Financial Results for the Second Quarter 2010

  August 12, 2010

   · 

  7 min read